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Abstract
Background: Angiotensin II/Angiotensin II type 1 receptor (AT1
DPH oxidase activation. Hsp70 regulates a diverse set of 
signaling pathways through their interactions with proteins. CHIP is a E3 ubiquitin ligase that 
targets proteins for polyubiquitination and degradation. Aim: We study whether Hsp70/CHIP 
contribute to the negative regulation of Nox4 after AT1 Methods/Results: Primary 
Angiotensin II (AII) or treated with Losartan (L) or Losartan plus Angiotensin II (L+AII). Losartan 
decreased AT1
(L+AII) revealing that Losartan was unable to abrogate AII effects on Nox4 expression and 
oxidative activity. Moreover, MG132 exposed PTCs (L) demostrated blocked ubiquitinated 
Nox4 degradation and increased 
Conversely, Hsp72 depletion reduced Nox4/Ubiquitin colocalization causing Nox4 upregulation 
due to proteosomal degradation inhibition, although Losartan treatment. Conclusion: Our 
study demonstrates that Hsp70 and CHIP mediates the ubiquitination and proteasomal 
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The effects of the Angiotensin II/Angiotensin II type 1 receptor (AT1R) are dependent 
on reactive oxygen species (ROS) production, which are stimulated by NADPH oxidase 
activation. ROS act as signalling molecules that mediate Angiotensin II-dependent signal 
transduction pathways [1, 2]. Data from in vivo and in vitro studies prove that locally 
generated Angiotensin II in proximal tubules (PT) induces renal injury through NADPH 
oxidase-dependent ROS production [3-6]. 
A role for the renin-angiotensin system in the development and/or maintenance 
of hypertension has been demonstrated in spontaneously hypertensive rats (SHR) [7]. 
mechanisms which are critical for renal injury [8]. 
Cloned from the kidney, Nox4 belongs to the Nox family of NADPH oxidases [9, 10]. 
Importantly, Nox4 is associated with mesangial cell, tubular cell or renal interstitial 
mechanisms by which Nox4 is regulated in the kidney have not been determined. Caveolin-1 
plays an important role as a platform for the compartmentalization of redox signaling 
events through NADPH oxidase-dependent production of ROS [12]. Thus, caveolin-1 is 
involved in Angiotensin II-induced NADPH activation in the kidney. Previously, we studied 
how caveolin-1 and Hsp70 possibly contribute to Nox4 expression regulation in SHR PT. We 
with caveolin-1. The translocation of Hsp70 to PT membranes in Losartan treated SHR might 
exert a cytoprotective effect through Nox4 downregulation [13]. 
In SHR vascular smooth muscle cells (VSMCs), we reported on how a functional 
association of Hsp70 with Nox4/p22 phox provides a mechanism, which explains an 
antioxidative effect of Losartan along with subsequent cytoskeletal integrity modulation 
[14]. 
Hsp70 regulates a diverse set of signaling pathways through its interaction with proteins 
[15]. Carboxy terminus of Hsp70 interacting protein (CHIP), is a cytoplasmic protein that 
interacts with Hsp70 through its tetratricopeptide repeat domain (TPR), whereas its U-box 
domain contains its E3 ubiquitin ligase activity. CHIP regulates the Hsp70 chaperone function 
in part by driving the molecular triage decision, which determines whether proteins enter 
the productive folding pathway or result in client substrate ubiquitination and proteasomal 
degradation [16]. 
Losartan down regulation of Nox4 levels is not clearly understood, here we analyze Hsp70 
and CHIP involvement. 
We identify that indeed Hsp70 and CHIP are Nox4-interacting proteins, which promote 
its ubiquitination and proteasomal degradation within Losartan effect on SHR PTCs.
Materials and Methods
Reagents
Antibodies against Megalin, caveolin-1 and AT1R were provided by Santa Cruz Biotechnology (Santa Cruz, 
CA, USA) and against Ubiquitin by Millipore (California).
Animals
Spontaneously Hypertensive Rats (SHR) and Wistar-Kyotto (WKY) male rats (8-10 weeks old) were 
used. Indirect systolic blood pressure was measured by the tail cuff method prior to experimentation using 
(Grass Medical Instruments). The average of 3 pressure readings was recorded. Body weight and systolic 
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This study was carried out in strict accordance with the recommendations in the Guide for the Care 
and Use of Laboratory Animals of the EAEC (Ethical Committee of Animal Experimentation of Argentina). 
All the experimental procedures of this study were previously approved by the Laboratory Animal Ethical 
Committee of the School of Medicine, Cuyo University, Mendoza (32/95 C.D.).
All surgery proceeding were performed under ketamine/xylazine (50 mg/kg and 2 mg/kg respectively) 
anesthesia, and all efforts were made to minimize animal suffering.
Cell Culture
The isolation of PTCs from SHR and WKY rats was performed as previously described [17, 18] with 
were desegregated and placed in ice cold Krebs-Henseleit solution (KHS) pH 7.4 and incubated with 95% 
O2/5% CO2 at 37 °C for 60 min. This suspension was centrifuged (60 g), the supernatant was discarded 
and the pellet re-suspended in ice cold KHS for thrice. Then, the pellet was re-suspended in 30 ml of ice-
cold Percoll 50% solution in KHS and centrifuged for 30 min at 4 °C at 15.000 rpm on a Beckman Coulter 
centrifuge (Beckman Coulter, Inc, CA, USA). The fourth fraction was re-suspended in ice-cold KHS, washed 
37 °C under 5% CO2
PTCs from SHR and WKY rats were stimulated with Angiotensin II (100 nM) for 15 min (AII), or 
treated with Losartan (10 μM) for 90 min (L) or with Losartan 90 min plus Angiotensin II for the last 15 
min in the same concentrations (L+AII). Non-treated cells were used as control (C).
Flow Cytometry
cytometry analysis showed a 71.3% of PTCs expressing Megalin and 0.23% of Aqp-2 positive cells. The 
were obtained as described Briones et al [19]. Equal amounts of proteins were separated by SDS-
polyacrylamide gel electrophoresis. After protein transfer to nitrocellulose membranes, membranes were 
blocked, blotted with primary antibodies and incubated with the appropriate horseradish peroxidase-
conjugated secondary antibodies. A SuperSignal West Pico chemiluminescent substrate kit (Pierce/
determined using the Image J software (Rasband WS, NIH, USA).
The RT-PCR assay was performed as it has been previously described [13]. The cDNA for Nox4 NADPH 
oxidase subunit (primer sequences: TCAACTGCAGCCTGATCCTTT and TCTGTGATCCGCGAAGGTAAG) and 
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Co-inmunoprecipitation assays were performed as described by Ramirez et al [20]. 
Nox4 was dissolved in a 0.1 M borate buffer pH 9.5, added to the Dynabeads M-280 Tosylactivated (Dynal 
Biotech). Normal Rabbit IgG (Sigma) was used as negative control.
Kidney microdissected proximal tubule membrane fractions were used as positive controls for Nox4 
antibody (4).
then with 0.2 M Tris pH 8.5 with 0.1% BSA and added to membrane samples containing equal quantities of 
protein. Incubated for 1 h, the samples were placed in the magnet and the supernatants were discarded. The 
beads were washed using a 0.1 M Na-phosphate and were suspended in sample buffer. Immunoprecipitated 
samples were separated on SDS-PAGE and immunoblotting for Nox4, Ubiquitin, Hsp70 and CHIP was 
performed as described above. The level of each protein was tested against the level of Nox4, and the results 
were expressed as the ratio.
4% paraformaldehyde, washed with PBS and blocked with 50 mM NH4Cl, permeabilized with 0.05% 
saponin/0.5% BSA in PBS and incubated over night with primary antibodies as below, washed and incubated 
The primary antibodies against Megalin, Hsp70, Nox4, CHIP and ubiquitin were used in a 1:100 dilution. 
The secondary antibodies used were Cy3-conjugated anti-mouse and Alexa 488-conjugated anti-rabbit 
co-localization from at least 50 cells were examined in each group in three independent experiments.
Hsp72 expression, transient transfections were done with 2 g/ml shHsp72-pSIREN-RetroQ vector 
and/or pSIREN-RetroQ empty vector (ev) (Mock-transfection control) for 72 h using LipofectamineTM 
2000 (Invitrogen, Carlsbad, CA) according to manufacturer’s recommendations. The shHsp72-pSIREN-
RetroQ vector was generously provided by Dr. MY Sherman (Boston University Medical School, Boston, 
MA, USA). The vector contained the sequence of human Hsp72 as target for RNA interference: shHsp72 
GAAGGACGAGTTTGAGCACAA (start 1961). No differences were shown between transfected empty vector 
DNR-DsRed-Express. After 72 h of transfection, cells were treated with AII or Losartan as previously 
4A).
PTCs were treated with AII or Losartan as previously described. The lucigenin derived 
chemiluminescence assay was performed to determine NADPH oxidase activity in membrane fractions 
[21]. 
Simon-OHM, Germany). Basal lectures in absence of NADPH was subtracted from each reading. Activity was 
expressed as percentage of arbitrary lights units. All assays were performed in duplicate.
Labsystems) at an excitation wavelength of 485 nm and an emission wavelength of 538 nm. Apocynin 50 
mM was used as a negative control. 




























Cell Physiol Biochem 2015;36:2183-2197
DOI: 10.1159/000430184
Published online: July 24, 2015
© 2015 S. Karger AG, Basel
www.karger.com/cpb 2187
Gil Lorenzo et al.: Nox4 Degradation by Hsp70 and CHIP
Cellular Physiology 
and Biochemistry
Data are presented as means ± SEM from at least 3 independent experiments. Groups were compared 




As to examine caveolin-1 and AT1R protein levels, immunoblot analysis was performed 
Fig. 1. Expression of caveolin-1 and AT1R at protein levels in PTCs. Losartan effect. 
antibody for Megalin (red) and with Hoechst to visualize the nuclei (blue). Scale bar 50 -
1R 
from WKY and SHR PTC membrane and cytosol fractions. Cells were stimulated with Angiotensin II (100 
nM) for 15 min (AII), treated with Losartan (10μM) for 90 min (L) or treated with Losartan for 90 min plus 
-
1
(lower right panel) were normalized to WKY control group PTC membranes.*p<0.05; **p<0.01; ***p<0.001 
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on SHR PTCs, after AII stimulation, we demonstrated higher levels of AT1R associated with 
a slight decrease on caveolin-1 protein levels when compared with Losartan treatment. 
Likewise, losartan decreased AT1R and increased caveolin-1 protein levels in VSMCs from 
SHR. The apparent association between the AT1R and caveolin-1 turnover suggests that 
caveolin-1 and AT1R may become physically associated with agonist stimulation.
oxidase and the functional relationship of AT1R with caveolae. Nox4 is the major source of 
ROS in renal tubule cells [10]. Downstream redox regulation of cell functions includes the 
synthesis of HSPs in the stress response, such as for Hsp72 (an inducible fraction of Hsp70). 
CHIP, an Hsp70-associated E3 ubiquitin ligase, promotes protein degradation through the 26 
S proteasome [16]. 
We hypothesized that the AT1R blockage would mediate Hsp70 translocation, the 
chaperone involved in its antioxidative mechanism. We found that Losartan increased Hsp70 
expression in SHR PTC membranes when compared with SHR PTC (C) and (AII) membranes. 
translocates to PTC membranes. Moreover, increased CHIP expression was shown in SHR 
PTC membranes after Losartan treatment when compared with PTC membranes stimulated 
. The lower Nox4 protein levels and the absence of differences 
 allow us to suggest that Hsp70/CHIP interaction may be involved in 
Nox4 proteasomal degradation after AT1R blockage.
treatment
In order to explore the potentially direct relationship between Nox4 and Hsp70/CHIP, 
Previously treated membrane fractions from SHR and WKY PTCs were 
immunoprecipitated with anti-Nox4 antibody to assess the possibility that Hp70/CHIP and 
Nox4 may become physically associated on AT1R inhibition. The immunoprecipitates were 
then subjected to western blot analysis, with mAbs against Hsp70, CHIP and Nox4. As shown 
interact with decreased Nox4 immunoprecipitation in the membrane fractions. Conversely, 
increased membrane Nox4 and lower Hsp70 and CHIP protein expression were shown in 
SHR PTCs (AII).
downregulated Nox4 exhibiting a punctate staining in a perinuclear distribution and at 
the plasma membrane in a pattern similar to the distribution of Nox4 in SHR PTCs (L) and 
Nox4 labeling was also shown around the nucleus. A clear overlap 
between increased Nox4 and CHIP with punctuate staining in a perinuclear distribution was 
These results reveal that both 
Hsp70 and CHIP are linked to a decrease in Nox4 expression, which probably induces Nox4 
ubiquitination when on route to its proteosomic degradation.
In order to further validate the association between Hsp70/CHIP and Nox4, SHR 
PTCs were transfected with shHsp72-pSIREN-RetroQ vector to transiently silence Hsp72 
(inducible fraction of Hsp70) expression and then exposed to the different treatments. 
analysis in SHR showed that Hsp72 knockdown led to 
higher Nox4 protein levels by 35% in PTCs (AII) and by 25% in (L+AII) treated PTCs with 
decreased CHIP protein levels by 35% in PTCs (L) when related to ev PTCs. Nox4 protein 
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Fig. 2. Hsp70/CHIP involvement in decreased Nox4 NADPH oxidase subunit expression after Angiotensin II 
type 1 receptor antagonist treatment. WKY and SHR PTCs were stimulated with Angiotensin II (100 nM) for 
15 min (AII), treated with Losartan (10 M) for 90 min (L) or treated with Losartan for 90 min plus Angio-
tensin II for the last 15 min (L+AII). (A) Immunoblot analysis of Nox4, Hsp70 and CHIP from PTC membrane 
lower expression of Nox4 were shown in PTCs (L) and (L+AII) related to PTCs (AII) membrane fractions. 
PTCs (C). (B) Quantitative RT-PCR of Nox4 in WKY and SHR PTCs. Representative gels of Nox4 mRNA. The 
-
SHR PTC membrane fractions were immunoprecipitated with anti-Nox4 antibody and immunoblotted with 
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Fig. 3. Losartan treated effect on colocalization of Hsp70 and CHIP with Nox4 in PTCs from SHR. (A) PTCs 
were double labeled with Hsp70 (green) and Nox4 (red) antibodies. Arrows indicate areas of colocalization 
*p<0.05; **p<0.01 vs PTCs at basal conditions. (B) PTCs were double labeled with CHIP (green) and Nox4 
(red) antibodies. Arrows indicate areas of colocalization (yellow) in the merge. Colocalization of Nox4 or 
expressed as mean ± SEM; 50 cells were analyzed for each treatment in three independent experiments. 
Scale bar 50 m.
Nox4 staining was observed in a perinuclear homogeneous pattern of distribution in (L) 
when related to ev PTCs. Nox4 intense staining in a dotted pattern was shown in transfected 
SHR PTCs (AII).
Hsp72 silencing of SHR PTCs, Losartan could not prevent an 
Angiotensin II enhanced Nox4 expression.
To determine whether Hsp70 could be involved in the regulation of PTCs oxidase 
functioning, we measured NADPH oxidase activity and ROS production in Hsp72 knockdown 
PTCs. 
Transfected PTCs with the plasmid to silence Hsp72 showed a higher NADPH oxidase 
activity and ROS production at basal conditions.
was sustained for up 900ms after Ang II addition. Apocynin, a selective inhibitor of NADPH 
oxidase, completely abolished the Ang II-stimulated response indicating that NADPH 
oxidase is the source of intracellular ROS (data not shown). The pre-exposure of SHR PTCs 
In SHR PTCs (L) and (L+AII), the Hsp72 silencing caused a near two-fold (L) and three-
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Fig. 4. Hsp72 knockdown effect on Nox4 NADPH oxidase and CHIP protein levels in SHR PTCs following 
Losartan treatment. SHR PTCs transfected with shHsp72-pSIREN-RetroQ vector to transient silence Hsp72 
expression and empty vector (ev). PTCs were stimulated with Angiotensin II (100 nM) for 15 min (AII), 
treated with Losartan (10 M) for 90 min (L) or treated with Losartan for 90 min plus Angiotensin II for 
blot **p<0.01 vs Nt PTCs. Bars are means ± SEM; n=2. (B) Immunoblot analysis of Nox4 and CHIP from PTC 
(lower left panel) and from cytosol fractions (lower right panel) are shown. *p<0.05 vs Nt PTCs. (C) Im-
images of SHR empty vector PTCs (L) (left), PTCs transfected with shHsp72-pSIREN-RetroQ plasmid vec-
tor (shHsp72) and treated or not with Losartan (central) and empty vector WKY PTCs (right) were double 
labeled with anti-Nox4 (red) and CHIP (green), antibodies. Nuclei were labeled with Hoechst (blue). Colo-
PTCs. Data are expressed as mean ± SEM; 50 cells were analyzed for each treatment in three independent 
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Fig. 5. Hsp72 knockdown effect on NADPH oxidase activity and intracellular ROS generation in SHR PTCs 
after Angiotensin II type 1 receptor antagonist treatment. (A) Lucigenin-enhanced chemiluminescence 
was used to measure NADPH oxidase activity in membrane fractions from empty vector PTCs and from 
knockdown Hsp72 PTCs exposed to Angiotensin II stimulation or Losartan treatment. *p<0.05; **p<0.01; 
***p<0.001 compared with Nt PTCs. •p<0.05; ••p<0.01 vs Losartan treated PTCs. Bars are means ± SEM; 
n=2. (B) The generation of intracellular ROS as assessed by -
cein diacetate  in empty vector PTCs and from Hsp72 knockdown PTCs exposed to 
Angiotensin II stimulation or Losartan treatment. *p<0.05; **p<0.01; ***p<0.001 vs Nt PTCs. •••p<0.001 vs 
Losartan treated PTCs. Values are presented as means ± SEM; n=2.
Losartan did not impair either NADPH oxidase activity or ROS generation in Hsp72 
knockdown SHR PTCs. In sum, our data show that Hsp70 is involved in the Losartan 
antioxidative effect.
In order to investigate the mechanism underlying Hsp70-mediated Nox4 downregulation, 
we studied the effect of Hsp70 on Nox4 ubiquitination and proteasomal degradation. SHR 
PTCs stimulated with AII or treated with Losartan, were exposed to the proteasome inhibitor 
MG132 to block degradation of ubiquitinated proteins. Immunoprecipitated Nox4 in SHR 
these proteins, in PTCs (L) exposed to MG132 treatment demonstrates an inhibited Nox4 
protein degradation. Thus, the increased ratio of Nox4/CHIP reveals Nox4 ubiquitination 
MG132 showed higher ubiquitinated Nox4 immunostaining with a perinuclear distribution 
 Hsp72 knockdown PTCs reveal 
decreased Nox4/Ubiquitin colocalization resulting in Nox4 upregulation because of the 
ubiquitination
In conjunction with these observations, Hsp70/CHIP promotes ubiquitinization and 
degradation of Nox4 through a proteasome-dependent pathway.
Discussion
We identify a novel role for Hsp70 as a negative regulator of Nox4. Hsp70/CHIP mediates 
the ubiquitination and proteasomal degradation of Nox4 thereby inhibiting Nox4-dependent 
protein expression, which is included within the Losartan antioxidative effect on SHR PTCs.
AT1R activation in PT by locally produced AII plays an important role in the pathogenesis 
of hypertension and renal injury. 
AII stimulation promotes AT1
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Fig. 6. Losartan effect on proteosomic degradation of Nox4 in SHR PTCs. PTCs were stimulated with Angio-
tensin II (100 nM) for 15 min (AII), treated with Losartan (10 μM) for 90 min (L) or with Losartan for 90 
min plus Angiotensin II for the last 15 min (L+AII) in presence and absence of 15 μM MG 132. (A) Immuno-
precipitation with anti-Nox4 antibody and immunoblotted with Nox4, Ubiquitin, Hsp70 and CHIP antibod-
and Hsp70/Nox4 of PTCs with or without MG132 treatment are shown. Bars means ± SEM; n=3. *p<0.05, 
**p<0.01, ***p<0.001vs PTCs (C). 
right panel), non-MG132 treated PTCs (upper left panel) and knockdown Hsp72 PTCs (lower left panel) 
 *p<0.05 vs 
PTCs (C). Data are expressed as mean ± SEM; 50 cells were analyzed for each treatment in three independ-
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represents an important target for the dynamic control of receptor signalling [22, 23]. 
Addressing SHR PTCs, we showed that higher AT1R protein levels were induced by the AII 
association with a slight reduction in caveolin-1 protein levels whereas Losartan treatment 
decreased AT1R and enhanced caveolin-1 protein levels. It is possible that AII stimulation 
results in caveolae internalization and the translocation to intracellular compartments in 
which the protein is degraded [22, 24]. Signal-transducing molecules bind to caveolin-1, 
functioning as redox signaling events through NADPH oxidase-dependent production of ROS 
[25, 26]. Nox4, which is abundantly expressed in kidney PT cells [10], is functionally linked 
to oxygen sensing, is implicated as a major source of renal ROS [27, 28]. Notwithstanding, the 
mechanism whereby Nox4 activity is regulated remains unclear.
Here, we investigate the role of Hsp70 in the mechanism responsible for the effect 
of Losartan on ROS through its negative regulation of Nox4. Hsp70 plays a critical role in 
the recovery of cells from stress [29]. In doing so, Hsp70 facilitates competing pathways of 
protein folding and degradation [30, 31], which provides cellular protection by decreased 
oxidative stress [15].
As support to this statement, the association of Hsp70 with NADPH, quinone 
oxidoreductase 1, was demonstrated to play an important role in the stability and 
functionality of the protein [32]. We provided evidence for the translocated Hsp70 and Nox4 
downregulation interaction in SHR microdiseccted proximal tubule membranes after AT1R 
blockage [13].
It is known that Hsp70 promotes the proteasomal degradation of proteins by recruiting 
the ubiquitin ligase CHIP, a key component of the chaperone-dependent quality control 
mechanism [33, 34]. 
they are partially or frankly misfolded, as is the case for most proteins binding to Hsp70 
through exposed hydrophobic residues [16, 35]. In this way, Nox4 is roughly divided in two 
large domains: an N-terminal cluster of hydrophobic membrane-spanning sequences, and a 
C-terminal protein domain [36].
Our results demonstrate that Losartan induces the physical association between the 
higher amounts of Hsp70/CHIP that co-precipitated with lower Nox4 as an effect of Hsp70/
CHIP interaction with Nox4 in SHR PTC membrane fractions. Nox4 protein downregulation 
and the unchanging Nox4 gene expression in SHR PTCs (L) suggest a chaperone involvement 
with Nox4 was shown in (L) and (L+AII)-treated SHR PTCs. The enhanced Hsp70 and CHIP 
expression contrasts with the lower Nox4 labelling occurring at the PTCs (L). Conversely, 
Hsp72 knockdown impaired the decay of Nox4 protein levels and decreased CHIP expression 
despite Losartan treatment. This shows that Hsp70 protein directly interacts with Nox4 and 
mediates selective Nox4 degradation by its association with CHIP. Hsp72 silencing in SHR 
PTCs (L) lead to similar values of NADPH oxidase activity and ROS generation as it does for 
transfected SHR PTCs (C). 
SHR increased oxidative activity in Hsp72 absence due to the ability of the plasmid vector to 
transiently silence PTCs. 
Taken together, these loss-of-function data indicate that Hsp70 is directly involved 
in Nox4 regulation through the physical and functional interactions that come under the 
antioxidative effect of Losartan.
Of note, CHIP acts to tilt the folding-refolding machinery toward a degradative pathway 
and it serves as a link between the chaperone and proteasome system; and, a recent study 
recruitment the E3 ubiquitin ligase CHIP, as a molecular mechanism in prolonged hypoxia 
[37].
The carboxy terminus of Hsp70-interacting protein (CHIP), a member of E3 ubiquitin 
ligase, functions as a link between Hsp70 and the proteasome systems, playing a vital role in 
maintaining the protein homeostasis in the cytoplasm [35].
Our results show that Hsp70 and E3 ubiquitin ligase CHIP interact with Nox4, by inducing 
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In this regard, PTCs exposed to the proteasome inhibitor MG132 blocked degradation of 
ubiquitinated Nox4, even with Losartan treatment. Hence, the higher Nox4/CHIP ratio 
that the increased colocalization of Nox4 with Ubiquitin following MG132 exposure was 
due to its ubiquitination reduction, regardless of Losartan treatment. These results indicate 
that Hsp70 and CHIP selectively regulate the protein stability of Nox4 in the presence of 
In conclusion, our data demonstrate that after AT1R blockage, Hsp70 interacts and 
cooperates with CHIP to regulate Nox4 ubiquitination and degradation providing a possible 
explanation for the mechanism that drives the Losartan antioxidative effect.
This study provides new insights into the mechanisms responsible for Losartan 
therapeutic intervention against oxidative stress-mediated renal tubular injury.
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